противозачаточная пилюля убивает или снижает в женщине либидо

[larsen]

- как именно, стесняюсь спросить? :27:

анализ мочи

[aprilneverends]

самое опасное для курильщиков это серьёзный очень риск тромба и да, тебе бы не выписали. Ты что? Ты себя большой опастности подвергаешь. Женщинам за 35 которые курят противозачаточные НЕ выписывают, это очень опасно.

я знаю я по молодости изучал про противозачаточные..в клинике консультантом практиковал. ну многое забыл, но про 35 лет и тыры пыры помнил
потому я и знал что наврать сказал я и опять покраснел
но про рак я не знал, честно. потому переспросил сейчас

[CCPC]

Если очень хочется побыстрее забеременеть, тёткам рекомендуется раком, во-первых, и на животе полежать подольше сразу после, во-вторых. :rolleyes:

Мама?8O

[Malishka]

:црз:
Эдик, волшебные таблетки изобрели в начале 60-х, так что за последние два года что-то изменилось не в таблетках и не в тётках. Явно. ;)

П.С. Убивает/снижает или нет - сказать не могу, никогда не принимала... курящим тёткам нельзя их, если не хотят резко повышенной угрозы рака.
Впрочем, достаточно почитать о побочных последствиях.
Прелесть что такое: набор веса (до сорока лишних кг), усиленное выпадение волос и тяжёлая депрессия. Не у всех и не всё сразу, конечно, но и чего-то одного достаточно... :веш:

Кошка, не пугай людей:

(From National Cancer Institute):
How do oral contraceptives affect breast cancer risk?

A woman’s risk of developing breast cancer depends on several factors, some of which are related to her natural hormones. Hormonal factors that increase the risk of breast cancer include conditions that may allow high levels of hormones to persist for long periods of time, such as beginning menstruation at an early age (before age 12), experiencing menopause at a late age (after age 55), having a first child after age 30, and not having children at all.

A 1996 analysis of worldwide epidemiologic data conducted by the Collaborative Group on Hormonal Factors in Breast Cancer found that women who were current or recent users of birth control pills had a slightly elevated risk of developing breast cancer. The risk was highest for women who started using OCs as teenagers. However, 10 or more years after women stopped using OCs, their risk of developing breast cancer returned to the same level as if they had never used birth control pills, regardless of family history of breast cancer, reproductive history, geographic area of residence, ethnic background, differences in study design, dose and type of hormone, or duration of use. In addition, breast cancers diagnosed in women after 10 or more years of not using OCs were less advanced than breast cancers diagnosed in women who had never used OCs. To conduct this analysis, the researchers examined the results of 54 studies. The analysis involved 53,297 women with breast cancer and 100,239 women without breast cancer. More than 200 researchers participated in this combined analysis of their original studies, which represented about 90 percent of the epidemiological studies throughout the world that had investigated the possible relationship between OCs and breast cancer (2).

The findings of the Women’s Contraceptive and Reproductive Experiences (Women’s CARE) study were in contrast to those described above. The Women’s CARE study examined the use of OCs as a risk factor for breast cancer in women ages 35 to 64. Researchers interviewed 4,575 women who were diagnosed with breast cancer between 1994 and 1998, and 4,682 women who did not have breast cancer. Investigators collected detailed information about the participants’ use of OCs, reproductive history, health, and family history. The results, which were published in 2002, indicated that current or former use of OCs did not significantly increase the risk of breast cancer. The findings were similar for white and black women. Factors such as longer periods of use, higher doses of estrogen, initiation of OC use before age 20, and OC use by women with a family history of breast cancer were not associated with an increased risk of the disease (3).

In a National Cancer Institute (NCI)-sponsored study published in 2003, researchers examined risk factors for breast cancer among women ages 20 to 34 compared with women ages 35 to 54. Women diagnosed with breast cancer were asked whether they had used OCs for more than 6 months before diagnosis and, if so, whether the most recent use had been within 5 years, 5 to 10 years, or more than 10 years. The results indicated that the risk was highest for women who used OCs within 5 years prior to diagnosis, particularly in the younger group (4).

How do oral contraceptives affect ovarian and endometrial cancer risk?

Studies have consistently shown that using OCs reduces the risk of ovarian cancer. In a 1992 analysis of 20 studies of OC use and ovarian cancer, researchers from Harvard Medical School found that the risk of ovarian cancer decreased with increasing duration of OC use. Results showed a 10 to 12 percent decrease in risk after 1 year of use, and approximately a 50 percent decrease after 5 years of use (5).

Researchers have studied how the amount or type of hormones in OCs affects ovarian cancer risk reduction. One of the studies used in the Harvard analysis, the Cancer and Steroid Hormone Study (CASH), found that the reduction in ovarian cancer risk was the same regardless of the type or amount of estrogen or progestin in the pill (6). A more recent analysis of data from the CASH study, however, indicated that OC formulations with high levels of progestin reduced ovarian cancer risk more than preparations with low progestin levels (7). In another recent study, the Steroid Hormones and Reproductions (SHARE) study, researchers investigated new, lower-dose progestins that have varying androgenic properties (testosterone-like effects). They found no difference in ovarian cancer risk between androgenic and nonandrogenic pills (8).

OC use in women at increased risk of ovarian cancer due to BRCA1 and BRCA2 genetic mutations has been studied. One study showed a reduction in risk, but a more recent study showed no effect (9, 10).

The use of OCs has been shown to significantly reduce the risk of endometrial cancer. This protective effect increases with the length of time OCs are used, and continues for many years after a woman stops using OCs (11).
How do oral contraceptives affect cervical cancer risk?

Evidence shows that long-term use of OCs (5 or more years) may be associated with an increased risk of cancer of the cervix (the narrow, lower portion of the uterus) (12). Although OC use may increase the risk of cervical cancer, human papillomavirus (HPV) is recognized as the major cause of this disease. Approximately 14 types of HPV have been identified as having the potential to cause cancer, and HPVs have been found in 99 percent of cervical cancer biopsy specimens worldwide (12). More information about HPV and cancer is available in Human Papillomaviruses and Cancer: Questions and Answers at http://www.cancer.gov/cancertopics/factsheet/risk/HPV on the Internet.

A 2003 analysis by the International Agency for Research on Cancer (IARC) found an increased risk of cervical cancer with longer use of OCs. Researchers analyzed data from 28 studies that included 12,531 women with cervical cancer. The data suggested that the risk of cervical cancer may decrease after OC use stops (13). In another IARC report, data from eight studies were combined to assess the effect of OC use on cervical cancer risk in HPV-positive women. Researchers found a fourfold increase in risk among women who had used OCs for longer than 5 years. Risk was also increased among women who began using OCs before age 20 and women who had used OCs within the past 5 years (14). The IARC is planning a study to reanalyze all data related to OC use and cervical cancer risk (12).
How do oral contraceptives affect liver cancer risk?

Several studies have found that OCs increase the risk of liver cancer in populations usually considered low risk, such as white women in the United States and Europe who do not have liver disease. In these studies, women who used OCs for longer periods of time were found to be at increased risk for liver cancer. However, OCs did not increase the risk of liver cancer in Asian and African women, who are considered high risk for this disease. Researchers believe this is because other risk factors, such as hepatitis infection, outweigh the effect of OCs (15).

[Кошка Мурка]

самое опасное для курильщиков это серьёзный очень риск тромба...

- ё-моё... у меня отец от тромба умер. А наследственный тромбофлебит бывает?

[Malishka]

я знаю я по молодости изучал про противозачаточные..в клинике консультантом практиковал. ну многое забыл, но про 35 лет и тыры пыры помнил
потому я и знал что наврать сказал я и опять покраснел
но про рак я не знал, честно. потому переспросил сейчас

небольшой риск есть и то при определённых условиях а не в разы и разы больше.

[Malishka]

- ё-моё... у меня отец от тромба умер. А наследственный тромбофлебит бывает?

Есть семейная наследственность в зависимости от того в каком возрасте он умер и при каких условиях развился тромб

[CCPC]

А наследственный тромбофлебит бывает?

Бывает..:rolleyes:

[Кошка Мурка]

Кошка, не пугай людей:
(From National Cancer Institute):
How do oral contraceptives affect breast cancer risk?

- а чего тогда везде тычут этим раком груди... :rolleyes:

[Malishka]

- а чего тогда везде тычут этим раком груди... :роллеыес:

риск повышен в полтора-1.7 раза но обыкновенный риск это 1 из 8 женщин заболевает раком груди в независимости от ничего

Нужно читать источники а не просто новости в телеке